GOVANCI

Trademark usage description

human pharmaceuticals for the prevention or treatment of auto-immune diseases, pulmonary diseases, cardiovascular diseases, gastro-intestinal diseases Read More

Classification Information

Class [005]
Human pharmaceuticals for the prevention or treatment of auto-immune diseases, pulmonary diseases, cardiovascular diseases, gastro-intestinal diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; anti-viral medications; anti-allergic medications; anti-inflammatory medications; anti-pain medications; and anti-infective medications; human vaccines

Classification kind code

Mark Details

Serial Number

1822577

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 6^th Jul 2018	Allowed
Submitted for opposition 51 on 6^th Jul 2018	Allowance Notice Sent
Submitted for opposition 42 on 21^st Mar 2018	Advertised
Submitted for opposition 26 on 1^st Mar 2018	Approved
Submitted for opposition 27 on 11^th Jan 2018	Approval Notice Sent
Submitted for opposition 22 on 12^th Dec 2017	Search Recorded
Submitted for opposition 20 on 12^th Dec 2017	Examiner's First Report
Submitted for opposition 31 on 15^th Feb 2017	Formalized
Submitted for opposition 1 on 14^th Feb 2017	Created
Submitted for opposition 30 on 13^th Feb 2017	Filed